论文部分内容阅读
近年来,由于抗心律失常药的广泛应用及心脏电生理研究的深入发展,对于抗心律失常药物的疗效及其促发心律失常的效应已引起医学界的重视。人们渴望应用一种副作用少疗效持久且能有效地控制和预防恶性心律失常及猝死的药物。据此,本文对52例室性心律失常患者口服妥卡律疗效进行了临床观察,现报道如下:临床资料一、对象:52例心律失常患者均为住院人,其中男37例,女15例,年龄30～74岁,平均53.4岁。病因:冠心病47例,其中心肌梗塞11例。心肌炎2例,风湿性心脏病、甲亢性心脏病及胆心综合症各1
In recent years, due to the wide use of anti-arrhythmic drugs and the further development of cardiac electrophysiology, the effect of anti-arrhythmic drugs and their effects on arrhythmia have drawn the attention of the medical community. People are eager to use a drug that has less side effects and long-lasting effects and can effectively control and prevent malignant arrhythmia and sudden death. Accordingly, this article 52 patients with ventricular arrhythmia oral echocardiography clinical efficacy, are reported as follows: Clinical data First, the object: 52 cases of arrhythmia patients were hospitalized, including 37 males and 15 females , Aged 30 to 74 years, an average of 53.4 years old. Etiology: Coronary heart disease in 47 cases, of which 11 cases of myocardial infarction. Myocarditis in 2 cases, rheumatic heart disease, hyperthyroidism heart disease and gallbladder syndrome 1